Affiliation
Cancer Research UK Cancer Genetics Group, Paterson Institute for Cancer Research, Wilmslow Road, Manchester M20 4BX, UK.Issue Date
2002-06-17
Metadata
Show full item recordAbstract
Tumour and normal tissue from 41 male cases of Wilms' tumour were screened to determine the presence of sequence variants in the glypican 3 (GPC3) gene. Two non-conservative single base changes were present in tumour tissue only. These findings imply a possible role for GPC3 in Wilms' tumour development.Citation
Somatic glypican 3 (GPC3) mutations in Wilms' tumour. 2002, 86 (12):1920-2 Br. J. CancerJournal
British Journal of CancerDOI
10.1038/sj.bjc.6600417PubMed ID
12085187Type
ArticleLanguage
enISSN
0007-0920ae974a485f413a2113503eed53cd6c53
10.1038/sj.bjc.6600417
Scopus Count
Collections
Related articles
- Methylation analysis of the glypican 3 gene in embryonal tumours.
- Authors: Boily G, Saikali Z, Sinnett D
- Issue date: 2004 Apr 19
- Expression of glypican 3 (GPC3) in embryonal tumors.
- Authors: Saikali Z, Sinnett D
- Issue date: 2000 Sep 20
- Glypican-3 expression in Wilms tumor and hepatoblastoma.
- Authors: Toretsky JA, Zitomersky NL, Eskenazi AE, Voigt RW, Strauch ED, Sun CC, Huber R, Meltzer SJ, Schlessinger D
- Issue date: 2001 Nov
- Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
- Authors: Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA
- Issue date: 1993 Dec
- Mutations of p53 in Wilms' tumors.
- Authors: Takeuchi S, Bartram CR, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, Koeffler HP
- Issue date: 1995 Jun